NIH: Allergen-Exposure Strategy Can Prevent Peanut Allergy

In light of recent allergen-exposure studies, an agency-sponsored panel has formally recommended early introduction of peanuts in an effort to prevent potentially life-threatening allergies.

Written byJoshua A. Krisch
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

PIXABAY, PUBLICDOMAINPICTURESRoughly 3 million Americans are living with peanut allergies, but new guidelines from the National Institute of Allergies and Disease (NIAID) suggest that early introduction of peanuts into infants’ diets may prevent a potentially life-threatening allergy from developing in the first place. The guidelines were published today (January 5) in the Journal of Allergy and Clinical Immunology.

“Living with peanut allergy requires constant vigilance. Preventing the development of peanut allergy will improve and save lives and lower health care costs,” NIAID Director Anthony Fauci said in a statement. “We expect that widespread implementation of these guidelines by health care providers will prevent the development of peanut allergy in many susceptible children and ultimately reduce the prevalence of peanut allergy in the United States.”

The guidelines are bolstered by the landmark 2015 LEAP study, funded in part by NIAID, which involved more than 500 babies and demonstrated that children at high risk of developing peanut allergies (due to preexisting eczema or egg allergies) experienced an 81 percent reduction in risk of developing the allergy if they were exposed to peanuts during early infancy. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies